Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M

Aug. 02, 2022 7:42 AM ETHarmony Biosciences Holdings, Inc. (HRMY)By: Urvi Shah, SA News Editor1 Comment
  • Harmony Biosciences press release (NASDAQ:HRMY): Q2 Non-GAAP EPS of $0.57 misses by $0.06.
  • Revenue of $107M (+44.9% Y/Y) beats by $6.25M.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.